• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    BioCryst Pharmaceuticals, Inc. (BCRX)

    -NasdaqGS
    11.42 Up 0.21(1.87%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Prev Close:11.21
    Open:11.10
    Bid:10.51 x 1000
    Ask:11.65 x 300
    1y Target Est:18.00
    Beta:3.58544
    Next Earnings Date: 5-Nov-15BCRX Earnings announcement
    Day's Range:11.03 - 11.43
    52wk Range:7.85 - 16.83
    Volume:424,931
    Avg Vol (3m):1,032,760
    Market Cap:836.39M
    P/E (ttm):N/A
    EPS (ttm):-0.43
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BCRX

    Comparison

    Symbol% ChgMkt Cap
    BCRXUp 1.87%836.39M
    GSKUp 0.10%99.70B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):19.85
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.64
    Quarterly EPS Est (Sep-15) :-0.22
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):0.79

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback